Norbert Pardi PhD

Dr Norbert Pardi holds a Ph.D. in biochemistry and genetics from the University of Szeged, Hungary. He has been working at the University of Pennsylvania since 2011 and currently holds an Associate Professor position at the Department of Microbiology of the Perelman School of Medicine. He received training from Drs Katalin Kariko and Drew Weissman at the University of Pennsylvania before he started his laboratory. His research interest is the development of mRNA-based therapeutics with particular focus on new-generation infectious disease vaccines. He explored the development of a novel vaccine platform using nucleoside-modified mRNA in lipid nanoparticles (LNPs) and used it to generate highly effective vaccines targeting various pathogens (influenza virus, coronaviruses, malaria and others). Dr. Pardi is a pioneer of the nucleoside-modified mRNA vaccine technology and published milestone papers in the field.